Edition:
United Kingdom

Aevi Genomic Medicine Inc (GNMX.OQ)

GNMX.OQ on NASDAQ Stock Exchange Global Market

1.27USD
21 Sep 2018
Change (% chg)

$-0.08 (-5.93%)
Prev Close
$1.35
Open
$1.36
Day's High
$1.36
Day's Low
$1.27
Volume
41,080
Avg. Vol
25,062
52-wk High
$2.64
52-wk Low
$0.84

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.138
Mar '18 0.00 -0.147
FY 2017 Dec '17 0.00 -0.129
Sep '17 0.00 -0.232
Jun '17 0.00 -0.216
Mar '17 0.00 -0.294
FY 2016 Dec '16 0.00 -0.229
Sep '16 0.00 -0.285
Jun '16 0.00 -0.350
Mar '16 0.00 -0.338
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 3 -0.15 -0.14 -0.17 -0.29
Quarter Ending Dec-18 3 -0.15 -0.14 -0.16 -0.31
Year Ending Dec-18 3 -0.58 -0.56 -0.61 -0.96
Year Ending Dec-19 3 -0.89 -0.61 -1.27 -1.35
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 0.46 0.93 0.89
Price to Sales (TTM) -- 114.98 5.74
Price to Book (MRQ) 2.94 15.51 5.00
Price to Tangible Book (MRQ) 2.94 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 21.18 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 38.12 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago 33.86 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -5.22 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 4.56 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 0.00 37.09 16.85
Interest Coverage (TTM) -30.67 -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -- -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -- -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -- -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,229,030 860,305,024
Net Income/Employee (TTM) -1,583,458 3,144,146 101,198,978
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -97.39 -0.15 11.13
Return on Assets - 5 Yr. Avg. -91.25 3.51 12.40
Return on Investment (TTM) -109.84 1.79 14.61
Return on Investment - 5 Yr. Avg. -103.34 2.56 16.13
Return on Equity (TTM) -109.84 3.28 16.33
Return on Equity - 5 Yr. Avg. -109.36 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 15.98 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aevi Genomic Medicine Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.65%
# of Holders: 47
Total Shares Held: 12,849,663
3 Mo. Net Change: -753,843
# New Positions: 4
# Closed Positions: 9
# Increased Positions: 12
# Reduced Positions: 17
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.